Luminal B breast carcinoma
MONDO:0021115A biologic subset of breast carcinoma defined by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen receptor (ER), and high expression of GGH, LAPTM4B, and CCNE1. This subtype of breast cancer is associated with a good prognosis, although not as favorable as the luminal A subtype.
Also known as: Luminal B, Luminal B breast cancer, Luminal B breast carcinoma, Luminal B estrogen receptor positive subtype of breast carcinoma, Luminal B oestrogen receptor positive subtype of breast carcinoma, Luminal B subtype of breast carcinoma
2812 clinical trials for this condition and its sub-types, 8 tagged with Luminal B breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Cancer-Killing virus plus immunotherapy shows promise in tough breast cancers
Disease control CompletedThis early study tested a combination of a modified herpes virus (T-VEC) and an immunotherapy drug (atezolizumab) in 28 women with aggressive breast cancer that did not fully disappear after standard chemotherapy. The virus was injected directly into tumors to kill cancer cells a…
Early phase 1 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Jun 26, 2026 15:12 UTC
-
New tool aims to ease tough talks on cancer drug resistance
Knowledge-focused CompletedThis study aimed to create a communication tool to help doctors and patients discuss when cancer stops responding to treatment. Researchers interviewed 128 people, including patients with certain breast cancers, metastatic uveal melanoma, parents of children with cancer, and heal…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:09 UTC